Zonisamide discontinuation due to psychiatric and cognitive adverse events
Autor: | White, J.R., Walczak, T.S., Marino, S.E., Beniak, T.E., Leppik, I.E., Birnbaum, A.K. |
---|---|
Zdroj: | Neurology (Ovid); August 2010, Vol. 75 Issue: 6 p513-518, 6p |
Abstrakt: | Zonisamide (ZNS) is an antiepileptic drug (AED) that has been associated with psychiatric adverse events (PAE) and cognitive adverse events (CAE); controlled studies evaluating these adverse events are limited. Our objectives were to 1) determine the incidence of PAE and CAE leading to the discontinuation of ZNS and 2) identify risk factors for PAE and CAE associated with the discontinuation of ZNS. |
Databáze: | Supplemental Index |
Externí odkaz: |
načítá se...